Navigation Links
Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Company's Phase III FDA Sickle Cell Treatment Trials
Date:11/19/2012

TORRANCE, Calif., Nov. 19, 2012 /PRNewswire/ -- Following a meeting on November 5, 2012 with the U.S. Food & Drug Administration (FDA), Dr. Yutaka Niihara offered the following remarks:

"The FDA's review group unanimously recommended that we proceed to complete our Phase III trial without any modification to the protocol. The trial is directed to study L-glutamine as a treatment for sickle cell disease.

"We currently have 220 patients enrolled at 32 study sites throughout the United States.  We will continue enrollment until the end of 2012, with an objective to complete the trial in 2013.

"The FDA's recommendation on proceeding to complete the trial follows the preliminary review of a subset of data from the Phase III clinical trial that was completed by an independent third party in August of this year.  Emmaus received its initial authorization from the FDA to begin the Phase III trial in August 2009, with the first patient enrolled in mid-2010.

"We continue to believe that Emmaus is the only company with a Phase III trial underway for a new sickle cell treatment.  With research grants and through the support of friends, family and private investors over the past 20 years, we have progressed to the point where we are confident in our treatment and hopeful it will be in the hands of patients worldwide in the not too distant future."

About Emmaus Medical, Inc.

Founded in 2000, Emmaus Medical, Inc. is a specialty pharmaceutical company, and subsidiary of Emmaus Life Sciences, Inc., dedicated to the discovery, development and commercialization of innovative and cost-effective treatments and therapies for rare diseases. The company is completing its Phase III clinical trial for a treatment for sickle cell disease and has entered into a collaborative agreement for the research, development and commercialization of regenerative medicine technology products. For more information, please visit '/>"/>

SOURCE Emmaus Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
2. Emmaus Medical Marks Progression of Phase 3 Sickle Cell Disease Clinical Trial During Sickle Cell Awareness Month
3. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
4. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
5. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
6. NIH Director Francis S. Collins, M.D., Ph.D. Selected as 2012 Pro Bono Humanum Honoree by Prix Galien USA
7. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
11. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. (OTC ... medical device company that develops and sells high performance ... its rights offering.  In addition, the concurrent temporary reduction ... expired on May 17, 2013. Nephros estimates ... from the rights offering.   A portion of the proceeds ...
(Date:5/23/2013)... May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... technology company, today scheduled a conference call to discuss ... year 2013, ended April 30, 2013. The call will ... 2013. The Company will report financial results for the ... close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... Arcion Therapeutics , a venture backed clinical ... today announced top-line results from a successful Phase 2b ... pain candidate, ARC-4558, in adult patients with painful diabetic ... 2 meeting with the United States Food and Drug ...
... , July 20 Allscripts (Nasdaq: ... selected the Allscripts Community Solution to power Huntington Health ... other health care providers across the San Gabriel Valley to connect ... where they are located or which clinical technologies they use. ...
Cached Medicine Technology:Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 2Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 3Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 2Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 3Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 5Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 6Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 7
(Date:5/25/2013)... (PRWEB) May 25, 2013 Communities of ... Texas. It is the fifth largest media market in the ... the number one visitor destination in Texas and a major ... to the American West as it is home to many ... will enjoy from sports to the arts. Residents and locals ...
(Date:5/25/2013)... SATURDAY, May 25 (HealthDay News) -- Many viruses and ... rabies and leptospirosis -- a bacteria-borne illness than can ... lurking at dog parks, according to a veterinarian. ... water and even the air, said Dr. Susan Nelson, ... Health Center. "Many of these serious diseases can be ...
(Date:5/25/2013)... States (PRWEB) May 25, 2013 ... largest underground shelter company in the US and ... underground structures for over 35 years. M.E. and ... U.S. Handbook of NBC Weapon Fundamentals and Shelter ... United States’ bible on shelter engineering. McCarthy is ...
(Date:5/25/2013)... May 25, 2013 Absolute Surgical Specialists, serving ... of the NALA’s businesses throughout the country participating in Shop ... participate in the nationwide event as he understands what military ... in the Army. He said, “I wanted to give something ... serve, but I live here too.” , Shop Local for ...
(Date:5/25/2013)... NY (PRWEB) May 25, 2013 ... problems, ranging from irritable bowel syndrome (IBS) to ... are among the most long-lasting, embarrassing, frustrating and ... natural foods for digestive health have provided ... there are many factors contributing to digestive health ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... Pa., Jan. 14 Three Rivers,Pharmaceuticals, LLC finalized ... Pharmaceuticals International (NYSE: VRX ). Valeant is,receiving ... "Adding Infergen to our growing portfolio is ... president and chief executive,officer. "This purchase is only ...
... GREEN BAY, Wis., Jan. 14 Shopko announced plans to ... corner of Broadway and,Dousman Street in downtown Green Bay. The ... that will be the first,major anchor in the 90 million ... is expected to open in fall of 2008., "This ...
... Join Forces to Escape the Mistaken ... Label of Pornography, HOLLYWOOD, ... the promotion of sensual products, sexual education and,relationship improvement is set to ... and singles with seminars and,products to enhance their love lives in a ...
... Forest Hospital,Foundation board of directors presented a merger proposal ... care system for northeastern Illinois,and the surrounding region. The ... hospital boards and would bring together the clinical,strength and ... County.*, As part of the proposal, the Lake ...
... with serious risks, FDA notes , , MONDAY, Jan. 14 (HealthDay ... sclerosis, may also be used for patients with a moderate ... U.S. Food and Drug Administration announced Monday. , But the ... a potentially deadly brain infection, as well as other side ...
... of Illinois have found a simple solution to a problem ... buffers used to maintain the pH of laboratory samples to ... team, headed by chemistry professor Yi Lu, developed a method ... a range of low temperatures. , The study appears this ...
Cached Medicine News:Health News:Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals 2Health News:Shopko Express Coming to Downtown Green Bay 2Health News:The First Annual LOVE L.A. Show Promotes Sensuality, Relationships and Sexual Education 2Health News:Lake Forest Hospital Proposes a New Health Care System in Lake County 2Health News:MS Drug Tysabri Approved for Crohn's Disease 2Health News:MS Drug Tysabri Approved for Crohn's Disease 3Health News:New buffer resists pH change, even as temperature drops 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: